Healthcare groups drug makers, device companies, insurers, and care providers under one industry-group label — not a single product cycle and not the same as a biotech index. Combined size is not a sector return. See how the ranking works.
368 U.S.-listed Healthcare companies with a market cap of at least $1B are ranked here by market capitalization, worth a combined $9.13T — 9.05% of the total market tracked on MarketCapLens. The most valuable is Eli Lilly and Company at $1.1T. As of September 22, 2026. Size ranking for research, not a sector recommendation.
| Industry | Companies | Combined cap | % of sector |
|---|---|---|---|
| Drug Manufacturers - General | 16 | $4.24T | 46.45% |
| Biotechnology | 170 | $1.24T | 13.58% |
| Medical - Diagnostics & Research | 27 | $875.8B | 9.59% |
| Medical - Devices | 39 | $757.6B | 8.30% |
| Medical - Healthcare Plans | 11 | $709.42B | 7.77% |
| Medical - Instruments & Supplies | 25 | $394.23B |
The largest company, Eli Lilly and Company (LLY), is 12.07% of Healthcare. The three largest — Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), and AbbVie Inc. (ABBV) — are 24.31% of the sector. The ten largest are 45.07%. Eli Lilly and Company is classified as Drug Manufacturers - General, which is also the largest industry in this sector by combined cap.
| Weight |
|---|
| 1 | Eli Lilly and CompanyLLY | $1.1T | $1,170.48 | +0.48% | 2.43M | 12.07% |
| 2 | Johnson & JohnsonJNJ | $648.72B | $269.19 | -0.10% | 5.65M | 7.11% |
| 3 | AbbVie Inc.ABBV | $468.77B | $265.32 | +0.32% | 2.73M | 5.13% |
| 4 | Merck & Co., Inc.MRK | $372.73B | $150.92 | +0.95% | 11.01M | 4.08% |
| 5 | UnitedHealth Group IncorporatedUNH | $338.69B | $372.95 | -1.22% | 4.49M | 3.71% |
| 6 | Novartis AGNVS | $268.53B | $141.28 | +0.21% | 1.54M | 2.94% |
| 7 | AstraZeneca PLCAZN | $261.12B | $168.37 | +0.16% | 2.31M | 2.86% |
| 8 | Thermo Fisher Scientific Inc.TMO | $243.49B | $658.52 | -0.04% | 2.1M | 2.67% |
| 9 | Amgen Inc.AMGN | $221.41B | $410.24 | +4.34% | 3.55M | 2.42% |
| 10 | Gilead Sciences, Inc.GILD | $189.3B | $152.67 | +1.40% | 5.05M | 2.07% |
| 11 | Abbott LaboratoriesABT | $179.49B | $103.73 | +0.73% | 8.25M | 1.97% |
| 12 | Novo Nordisk A/SNVO | $174.96B | $39.40 | -1.01% | 24M | 1.92% |
| 13 | Pfizer Inc.PFE | $159.19B | $27.93 | +0.68% | 26.65M | 1.74% |
| 14 | Danaher CorporationDHR | $155.44B | $221.12 | +2.45% | 4.63M | 1.70% |
| 15 | Intuitive Surgical, Inc.ISRG | $142.05B | $402.09 | +0.11% | 1.83M | 1.56% |
| 16 | Vertex Pharmaceuticals IncorporatedVRTX | $130.71B | $514.99 | +0.84% | 1.38M | 1.43% |
| 17 | Bristol-Myers Squibb CompanyBMY | $127.16B | $62.25 | -0.59% | 13.52M | 1.39% |
| 18 | Medtronic plcMDT | $116.19B | $90.77 | -1.07% | 14.06M | 1.27% |
| 19 | CVS Health Corp.CVS | $111.13B | $87.10 | -0.57% | 8.68M | 1.22% |
| 20 | Stryker CorporationSYK | $105.45B | $275.07 | +0.32% | 2.34M | 1.15% |
| 21 | McKesson CorporationMCK | $104.34B | $891.23 | +0.54% | 853.11K | 1.14% |
| 22 | SanofiSNY | $102.08B | $42.51 | +0.02% | 3.08M | 1.12% |
| 23 | GSK plcGSK | $101.62B | $50.72 | -0.70% | 4.3M | 1.11% |
| 24 | HCA Healthcare, Inc.HCA | $94.85B | $438.12 | +2.85% | 1.5M | 1.04% |
| 25 | Elevance Health Inc.ELV | $87.27B | $402.43 | -1.68% | 1.11M | 0.96% |
| 26 | Regeneron Pharmaceuticals, Inc.REGN | $82.82B | $803.90 | +0.72% | 599.12K | 0.91% |
| 27 | Moderna, Inc.MRNA | $72.44B | $182.56 | +5.56% | 23.78M | 0.79% |
| 28 | Cigna CorporationCI | $72.33B | $273.74 | -0.27% | 1.47M | 0.79% |
| 29 | Boston Scientific CorporationBSX | $66.77B | $44.92 | +2.74% | 21.02M | 0.73% |
| 30 | Cencora, Inc.COR | $61.18B | $314.43 | -0.65% | 763.96K | 0.67% |
| 31 | Takeda Pharmaceutical Company LimitedTAK | $60.3B | $18.95 | +0.32% | 1.4M | 0.66% |
| 32 | argenx SEARGX | $59.94B | $963.79 | -2.47% | 304.38K | 0.66% |
| 33 | Natera, Inc.NTRA | $55.98B | $390.90 | +5.47% | 1.52M | 0.61% |
| 34 | Cardinal Health, Inc.CAH | $52B | $222.04 | -1.64% | 2.71M | 0.57% |
| 35 | Edwards Lifesciences CorporationEW | $51.12B | $88.78 | +0.50% | 3.53M | 0.56% |
| 36 | Becton, Dickinson and CompanyBDX | $50.42B | $183.00 | +1.27% | 1.43M | 0.55% |
| 37 | Agilent Technologies, Inc.A | $47.24B | $167.25 | +3.28% | 3.71M | 0.52% |
| 38 | Teva Pharmaceutical Industries LimitedTEVA | $46.03B | $39.52 | -1.35% | 4.54M | 0.50% |
| 39 | Humana Inc.HUM | $44.66B | $371.93 | -1.76% | 851.06K | 0.49% |
| 40 | IQVIA Holdings Inc.IQV | $44.46B | $270.09 | +0.08% | 939.94K | 0.49% |
| 41 | Waters CorporationWAT | $41.8B | $425.74 | +0.43% | 648.33K | 0.46% |
| 42 | IDEXX Laboratories, Inc.IDXX | $41.14B | $521.50 | +1.20% | 476.53K | 0.45% |
| 43 | Revolution Medicines, Inc.RVMD | $41B | $192.86 | +0.05% | 1.88M | 0.45% |
| 44 | Haleon plcHLN | $40.74B | $9.25 | -1.18% | 29.49M | 0.45% |
| 45 | BeOne Medicines AGONC | $39.33B | $368.08 | +0.66% | 258.74K | 0.43% |
| 46 | Illumina, Inc.ILMN | $37.44B | $247.46 | +3.62% | 2.64M | 0.41% |
| 47 | DexCom, Inc.DXCM | $33.79B | $89.53 | +0.40% | 7.25M | 0.37% |
| 48 | Alnylam Pharmaceuticals, Inc.ALNY | $33.67B | $251.65 | +3.00% | 1.13M | 0.37% |
| 49 | Biogen Inc.BIIB | $33.3B | $225.36 | +2.87% | 1.11M | 0.36% |
| 50 | ResMed Inc.RMD | $32.2B | $221.97 | -0.73% | 979.42K | 0.35% |
| 51 | Alcon Inc.ALC | $31.99B | $65.59 | +1.11% | 940.92K | 0.35% |
| 52 | Centene Corp.CNC | $31.26B | $63.28 | -2.63% | 6.09M | 0.34% |
| 53 | Zoetis Inc.ZTS | $30.56B | $72.89 | +2.19% | 3.83M | 0.33% |
| 54 | Mettler-Toledo International Inc.MTD | $30.12B | $1,490.76 | +4.22% | 298.91K | 0.33% |
| 55 | GE HealthCare Technologies Inc.GEHC | $29.93B | $66.27 | +2.25% | 3.88M | 0.33% |
| 56 | Medline Inc.MDLN | $29.11B | $34.43 | +7.73% | 10.32M | 0.32% |
| 57 | Roivant Sciences Ltd.ROIV | $27.61B | $38.22 | -1.97% | 6.75M | 0.30% |
| 58 | Insmed IncorporatedINSM | $26.19B | $120.82 | -0.15% | 2.4M | 0.29% |
| 59 | West Pharmaceutical Services, Inc.WST | $26.12B | $371.09 | +2.57% | 730.42K | 0.29% |
| 60 | Royalty Pharma plcRPRX | $25.93B | $58.49 | +0.09% | 2.69M | 0.28% |
| 61 | Quest Diagnostics IncorporatedDGX | $25.92B | $234.85 | -4.10% | 2.72M | 0.28% |
| 62 | Incyte CorporationINCY | $25.73B | $126.93 | +1.83% | 1.64M | 0.28% |
| 63 | Labcorp Holdings Inc.LH | $25.55B | $311.54 | -2.94% | 1.9M | 0.28% |
| 64 | BioNTech SEBNTX | $25.34B | $100.87 | +2.93% | 1.05M | 0.28% |
| 65 | Koninklijke Philips N.V.PHG | $24.41B | $24.97 | +0.28% | 568.26K | 0.27% |
| 66 | Guardant Health, Inc.GH | $23.77B | $177.16 | +1.89% | 2.21M | 0.26% |
| 67 | Genmab A/SGMAB | $21.62B | $35.22 | +1.53% | 2.3M | 0.24% |
| 68 | United Therapeutics CorporationUTHR | $21.12B | $497.59 | +0.91% | 398.25K | 0.23% |
| 69 | Tenet Healthcare CorporationTHC | $21.1B | $262.06 | +0.42% | 779.33K | 0.23% |
| 70 | STERIS plcSTE | $20.35B | $208.79 | +0.88% | 624.62K | 0.22% |
| 71 | Viatris Inc.VTRS | $20.01B | $17.18 | +0.47% | 5.24M | 0.22% |
| 72 | Zimmer Biomet Holdings, Inc.ZBH | $18.18B | $93.98 | -0.36% | 1.68M | 0.20% |
| 73 | Medpace Holdings, Inc.MEDP | $17.59B | $630.19 | +0.96% | 302.65K | 0.19% |
| 74 | Revvity, Inc.RVTY | $15.99B | $143.31 | -0.20% | 2.86M | 0.18% |
| 75 | Solventum CorporationSOLV | $15.37B | $88.75 | -0.10% | 651.23K | 0.17% |
| 76 | Jazz Pharmaceuticals plcJAZZ | $15.11B | $240.57 | -0.37% | 481.99K | 0.17% |
| 77 | Ascendis Pharma A/SASND | $14.76B | $237.57 | -0.01% | 548.3K | 0.16% |
| 78 | Exelixis, Inc.EXEL | $14.62B | $58.15 | +1.63% | 1.86M | 0.16% |
| 79 | Neurocrine Biosciences, Inc.NBIX | $14.3B | $142.25 | -1.19% | 1.21M | 0.16% |
| 80 | Charles River Laboratories International, Inc.CRL | $13.73B | $285.11 | +2.19% | 1.11M | 0.15% |
| 81 | Summit Therapeutics Inc.SMMT | $13.66B | $17.12 | +1.30% | 4.59M | 0.15% |
| 82 | Halozyme Therapeutics, Inc.HALO | $13.66B | $115.13 | +3.30% | 4.13M | 0.15% |
| 83 | BridgeBio Pharma, Inc.BBIO | $13.56B | $69.23 | +3.98% | 3.74M | 0.15% |
| 84 | Tempus AI, Inc.TEM | $13.52B | $77.19 | -1.08% | 5.97M | 0.15% |
| 85 | ICON Public Limited CompanyICLR | $12.8B | $167.11 | -1.44% | 1.06M | 0.14% |
| 86 | Corcept Therapeutics IncorporatedCORT | $12.7B | $117.51 | +3.29% | 746.6K | 0.14% |
| 87 | Penumbra, Inc.PEN | $12.58B | $319.39 | +0.19% | 791.87K | 0.14% |
| 88 | BioMarin Pharmaceutical Inc.BMRN | $12.25B | $63.37 | -1.08% | 1.96M | 0.13% |
| 89 | Baxter International Inc.BAX | $12.24B | $23.68 | +3.27% | 7.3M | 0.13% |
| 90 | Encompass Health CorporationEHC | $12.18B | $122.76 | +0.99% | 1.12M | 0.13% |
| 91 | Fresenius Medical Care AG & Co. KGaAFMS | $12.09B | $22.50 | +1.26% | 954.28K | 0.13% |
| 92 | Madrigal Pharmaceuticals, Inc.MDGL | $11.99B | $518.83 | -0.60% | 266.06K | 0.13% |
| 93 | DaVita Inc.DVA | $11.79B | $183.72 | +0.76% | 529.34K | 0.13% |
| 94 | Smith & Nephew plcSNN | $11.55B | $27.50 | -0.69% | 897.68K | 0.13% |
| 95 | Elanco Animal Health IncorporatedELAN | $11.45B | $22.92 | +2.18% | 5.61M | 0.13% |
| 96 | Bio-Techne CorporationTECH | $11.36B | $72.55 | +0.11% | 3.42M | 0.12% |
| 97 | BrightSpring Health Services, Inc. Common StockBTSG | $11.1B | $56.55 | +1.24% | 2.07M | 0.12% |
| 98 | Align Technology, Inc.ALGN | $10.98B | $153.29 | +4.36% | 940.22K | 0.12% |
| 99 | Universal Health Services, Inc.UHS | $10.85B | $179.29 | +2.60% | 791.33K | 0.12% |
| 100 | The Cooper Companies, Inc.COO | $10.78B | $55.29 | +2.16% | 2.69M | 0.12% |
| 4.32% |
| Drug Manufacturers - Specialty & Generic | 24 | $268.79B | 2.94% |
|---|
| Medical - Care Facilities | 31 | $241.82B | 2.65% |
|---|
| Other | 25 | $401.44B | 4.40% |
|---|
Read the industry rows as labeled: drug manufacturers, medical devices, diagnostics, managed care, and providers sit side by side. Combined market cap is equity size, not a health-care return, and it is not a pipeline score.